114 related articles for article (PubMed ID: 20208325)
1. Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Li J; Merl MY; Saif MW
JOP; 2010 Mar; 11(2):151-3. PubMed ID: 20208325
[TBL] [Abstract][Full Text] [Related]
2. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Lazenby JM; Saif MW
JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
[TBL] [Abstract][Full Text] [Related]
3. The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Merl MY; Li J; Saif MW
JOP; 2010 Mar; 11(2):148-50. PubMed ID: 20208324
[TBL] [Abstract][Full Text] [Related]
4. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Richter J; Saif MW
JOP; 2010 Mar; 11(2):139-43. PubMed ID: 20208322
[TBL] [Abstract][Full Text] [Related]
5. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
6. Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Richter J; Saif MW
JOP; 2010 Mar; 11(2):144-7. PubMed ID: 20208323
[TBL] [Abstract][Full Text] [Related]
7. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
[TBL] [Abstract][Full Text] [Related]
8. [Non surgical treatment of pancreatic cancers].
Bleiberg H; Gerard B; Hendlisz A; Jagodzinski R
J Chir (Paris); 1997 Sep; 134(4):169-73. PubMed ID: 9499945
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Sharma C; Horowitz D; Chabot J; Saif MW
JOP; 2011 Jul; 12(4):343-6. PubMed ID: 21737892
[TBL] [Abstract][Full Text] [Related]
11. Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Bussom S; Saif MW
JOP; 2010 Mar; 11(2):128-30. PubMed ID: 20208319
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant postoperative therapy of gastrointestinal malignancies.
Ilson DH; Kelsen DP
Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
[TBL] [Abstract][Full Text] [Related]
13. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
14. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merl MY; Abdelghany O; Li J; Saif MW
JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
[TBL] [Abstract][Full Text] [Related]
15. [Palliative chemotherapy in metastatic and locally advanced gastrointestinal tumor].
Dippold W
Zentralbl Chir; 1998; 123(6):722-4. PubMed ID: 9703647
[TBL] [Abstract][Full Text] [Related]
16. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
17. Clinical overview: adjuvant therapy of gastrointestinal cancer.
Macdonald JS
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
19. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
20. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Alsamarai S; Libutti SK; Saif MW
JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
